BIO-key International Inc. (NASDAQ:BKYI) Short Interest Update

BIO-key International Inc. (NASDAQ:BKYI) was the target of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 224,434 shares, a decline of 27.8% from the February 12th total of 310,850 shares. Based on an average daily volume of 275,973 shares, the short-interest ratio is presently 0.8 days. Approximately 2.2% of the company’s shares are sold short. Approximately 2.2% of the company’s shares are sold short. Based on an average daily volume of 275,973 shares, the short-interest ratio is presently 0.8 days.

BIO-key International Stock Down 2.1%

BKYI stock opened at $0.65 on Monday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.26 and a quick ratio of 1.13. The stock has a market capitalization of $7.03 million, a P/E ratio of -0.62 and a beta of 0.41. BIO-key International has a fifty-two week low of $0.51 and a fifty-two week high of $1.97. The business has a 50-day moving average of $0.62 and a 200-day moving average of $0.71.

Institutional Trading of BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC lifted its holdings in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the quarter. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. 26.51% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

BKYI has been the subject of several analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, January 21st. Wall Street Zen upgraded shares of BIO-key International to a “sell” rating in a report on Saturday, January 3rd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, BIO-key International has a consensus rating of “Sell”.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.